An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings from the PRIMARY2 trial ...
Mar 12, 2026
0
25
Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) diagnostic testing to establish ...
Jul 15, 2024
0
29
MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests
Mar 29, 2024
0
66
According to a research letter published in JAMA Internal Medicine, prostate cancer screening frequently results in biopsies that find clinically insignificant cancer or no cancer at all.
A Yale-led study examines the potential environmental benefits of more carefully selecting patients for prostate biopsy in a way that can also spare low-yield and potentially harmful procedures.
Mar 1, 2023
0
29
